Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2014 Aug;58(8):4993–4994. doi: 10.1128/AAC.03463-14

Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis

Shahul Hameed P a, Suresh Solapure a, Kakoli Mukherjee a, Vrinda Nandi a, David Waterson a, Radha Shandil a, Meenakshi Balganesh a, Vasan K Sambandamurthy a, Anand Kumar Raichurkar a, Abhijeet Deshpande a, Anirban Ghosh a, Disha Awasthy a, Gajanan Shanbhag a, Gulebahar Sheikh a, Helen McMiken b, Jayashree Puttur a, Jitendar Reddy a, Jim Werngren c, Jon Read b, Mahesh Kumar a, Manjunatha R a, Murugan Chinnapattu a, Prashanti Madhavapeddi a, Praveena Manjrekar a, Reetobrata Basu a, Sheshagiri Gaonkar a, Sreevalli Sharma a, Sven Hoffner c, Vaishali Humnabadkar a, Venkita Subbulakshmi a, Vijender Panduga a
PMCID: PMC4135989

ERRATUM

Volume 58, no. 1, p. 61–70, 2014. Page 63: In Table 1, the substitution in the R3 group for compounds 4 to 9 was erroneously shown to be attached at the C-5 position of the triazole ring. The correct attachment should be at the C-2 position of the triazole ring. The corrected structures for the R3 group are shown below.

TABLE 1.

Structure-activity relationshipa

graphic file with name zac00814-3154-t01.jpg

Open in a new tab
a

SC, supercoiling assay; ND, not determined.

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES